Atalante exoskeletonamyotrophic lateral sclerosisALSNCT06199284CPP Nord-Ouest Iusual care
… primary outcome of the study is safety and tolerability of the Atalante exoskeleton. Secondary outcomes include: participants’ subjective impact an…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Atalante exoskeleton ×
Atalante exoskeleton
This drug is selected. Its supporting articles are shown below.